IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Dr Lalchandani Labs IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 4.20 Cr. The company is based in New Delhi and caters to Healthcare sector. Navigant Corporate Advisors is the merchant banker of Dr Lalchandani Labs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd February 2018.
Dr Lalchandani Labs IPO open date is 25th April 2018 and close date is 27th April 2018. IPO Allotment Date is [●] and Listing date is 9th May 2018.
IPO
Size:
₹ 4.20 Cr.
Avg IPO Size (Sector Based)
: ₹
27.11 cr.
Sector: Healthcare
SME
IPO so far:
45
Merchant Banker:
Navigant Corporate
SME
IPO by BRLM so far:
23
City:
New Delhi
SME
IPO so far:
158
Revenue (annualised):
₹
2.57
cr. 
PE
Ratio:
10.00x
Average Sector PE Ratio: 19.10x
Dr Lalchandani Labs IPO size is ₹ 4.20 Cr. with IPO price of ₹ 30.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Navigant Corporate Advisors Limited is the book-running lead manager of the Dr Lalchandani Labs IPO. Cameo Corporate Services Limited is the Registrar and Market Maker is Nnm Securities Private Limited for Dr Lalchandani Labs IPO.
Dr Lalchandani Labs IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Dr Lalchandani Labs IPO, based in New Delhi, operates in the Healthcare sector with a focus on provider of diagnostic and related healthcare tests. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Dr Lalchandani Labs IPO size is ₹ 4.20 Cr. with fresh issue size of ₹ 4.20 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Dr Lalchandani Labs IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Dr Lalchandani Labs IPO allotment status on the registrars website, Cameo Corporate Services Limited . Dr Lalchandani Labs IPO refund dates are [●].
Dr Lalchandani Labs IPO is expected to be listed on 9th May 2018.
The upper price band for the Dr Lalchandani Labs IPO is set at ₹ 30.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Dr Lalchandani Labs IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Dr Lalchandani Labs IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 27th April 2018. After submission, funds are blocked until the basis of allotment of Dr Lalchandani Labs IPO is finalised.
The merchant banker for Dr Lalchandani Labs IPO is Navigant Corporate Advisors Limited . Navigant Corporate Advisors Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Dr Lalchandani Labs IPO RHP for further details.
The registrar for Dr Lalchandani Labs IPO is Cameo Corporate Services Limited . Investors can go to Cameo Corporate Services Limited registrar website for IPO allotment status, refund processing, and other queries related to Dr Lalchandani Labs IPO through their official website or helpline.
Dr Lalchandani Labs IPO was subscribed 4.96 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 4.20 Cr.
Avg IPO Size (Sector Based)
:
₹ 27.11 Cr.
Sector: Healthcare
SME
IPO so far:
45
Merchant Banker:
Navigant Corporate
SME
IPO by BRLM so far:
23
City:
New Delhi
SME
IPO so far:
158
Revenue (annualised):
₹ 2.57 cr.
PE
Ratio:
10.00x
Average Sector PE Ratio: 19.10x
Dr Lalchandani Labs IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Dr Lalchandani Labs Financial Review Page
Merchant Banker(s) of Dr Lalchandani Labs IPO: Navigant Corporate Advisors Limited
Dr Lalchandani Labs IPO subscription was 4.96 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Dr Lalchandani Labs IPO listed at a listing price of 28.50 against the offer price of 30.00.
The current market price of Dr Lalchandani Labs is 19.39.
Why Us?
